SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-22-000018
Filing Date
2022-04-29
Accepted
2022-04-29 13:02:54
Documents
71
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20220331.htm   iXBRL 10-Q 1714033
2 EX-10.1 brmn-31mar22xexx101.htm EX-10.1 199725
3 EX-31.1 exhibit311-31mar22x10q.htm EX-31.1 8894
4 EX-31.2 exhibit312-31mar22x10q.htm EX-31.2 9137
5 EX-32.1 exhibit321-31mar22x10q.htm EX-32.1 5241
11 GRAPHIC image_0.jpg GRAPHIC 8163
  Complete submission text file 0001048477-22-000018.txt   7570608

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20220331.xsd EX-101.SCH 44466
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20220331_cal.xml EX-101.CAL 71071
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20220331_def.xml EX-101.DEF 227502
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20220331_lab.xml EX-101.LAB 524738
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20220331_pre.xml EX-101.PRE 355128
65 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20220331_htm.xml XML 1425098
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 22872860
SIC: 2834 Pharmaceutical Preparations